Descent into bankruptcy

Discussion in 'Depomed' started by anonymous, Oct 12, 2017 at 1:22 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Would have been better off with Schoeneck and the old BOD. The attitude around the office now is no one cares. The company (and our careers) have simply become an ATM machine for the hedge funds who are shorting this company as management and sales falter.

    The only hope is someone swoops in with a hostile take over here. Otherwise the current players are set on a path to zero, and no one is going to stop them.
     

  2. anonymous

    anonymous Guest

    Nobody is buying this company on a way down the bottom of the ocean. All it did is make tons of money for short sellers and for all the fomer
    Abbott semi retired team.
     
  3. anonymous

    anonymous Guest

    Depomed was already struggling in a shrinking market and then to have backorders on top of that. We will lose so many writers and patients. We will not be able to bounce back from this mistake. This could be the nail in the coffin for depomed.
     
  4. anonymous

    anonymous Guest

    Definitely agree that the HR VP who came from Abbott shouldn't be paid anything. She did absolutely nothing except preside over a mass exodus at all levels.
     
  5. anonymous

    anonymous Guest

    The management of this company are and have been appalling for a long time, this latest round of clowns just goes with the expectancy. The SVP of HR, Sharon Larkin doesn't actually listen to concerns, she is another that is being paid handsomely to do nothing. Come to think of it, take a look at the amount of HR people that are employed at a company that has no business? What is their role in the culture and motivation? Why do we have such an extensive Snr Director group in Commercial? What on earth are they actually doing? Do we really need the amount of people across Finance? several VP's? Really? What are they doing? In fact lets ask ourselves, what is anyone doing? Arthur and the Knights are an absolute shower of shit, appalling. I remember our SVP General Counsel once saying "I just want to make enough money to pay off my mortgage" really? How much money do you need? Is 2MM+ per year enough or are you living in a 100MM home? What's the point when we have that mentality? And Arthur? Really? What on earth are we even thinking, a guy that turns up to a Sales Conference and tells the leading sales teams in front of their spouses and partners that essentially they suck and they should never be on a trip that awarded them. Arthur, they are the only people you should be counting on. But then, you're making 2MM+ as well, no real need to worry about saving this company, not that you have a clue how to, just keep milking the cow until it's udders are dry, then put a bullet in it and on to the next. I feel sorry for those of us that have been trying to help this company, maybe if you'd treated the workers better instead of lining your pockets you wouldn't have the don't care attitude. You all suck and should be ashamed of yourselves, but you're not, because you don't care either.
     
  6. anonymous

    anonymous Guest


    I think Arthur still cares because he thinks he's such a bad ass who can win in every situation. He won't be able to talk about how "he's never fallen short of a plan by more than 10%" or whatever he said on his first day.
     
  7. anonymous

    anonymous Guest

    we keep talking about how great a product Nucynta is and that we'll be OK once the opioids scare blows over.

    So if it really comes to the point where we can't Service our debt, could we use Chapter 11 to survive, arguing that there is significant long term potential in the company? We're just getting our asses handed to us for the time being?
     
  8. anonymous

    anonymous Guest

    The nail is the amount of people leaving and we can't hire talent. Who would actually come here, we are at an all time low and seem to be milking the last juice out of the company.
     
  9. anonymous

    anonymous Guest


    GREAT POINT. Retaining/hiring talent is the #1 issue at this company. Why? Because I personally know at least 7 Top 25 Pain reps that have interviewed elsewhere in the last 6 weeks, including myself. And I am in the Top 25.
     
  10. anonymous

    anonymous Guest

    All of which underscores that our HR VP hasn't done shit to improve the situation.
     
  11. anonymous

    anonymous Guest

    How about this? The industry sucks right now and you have a company that has money and is looking to diversify. If you think the grass is greener then go...otherwise aporeciate what you have and stfu...pussies.
     
  12. anonymous

    anonymous Guest

    I disagree. There are actually a decent amount of Specialty jobs posted, and if you read, you know more are coming in the short term. Is the company cash flow positive? Yes. Is it a revolving door at the leadership level? Yes. Remember, many of us are heavily invested in this company right now, so don’t get on your pedestal and tell us how to feel. Many of us have worked our asses off for years, only to see things get pissed away. Good products, but God-awful senior leadership right now. This is the legacy of Depomed.
     
  13. anonymous

    anonymous Guest

    Why do we continue to hire recycled CEOs that failed at their previous companies? The pharma industry does not hire "outside the box". Same old retreads over and over again!! That is why we are filing for bankruptcy. Wake up Board of Directors and embrace radical thinking and change!! Totally sick of our company and industry!
     
  14. anonymous

    anonymous Guest

    Hahahaha....all right....just less revenues...say around 10%....and Shareprice down by 80%...all right ..bk...all right
     
  15. anonymous

    anonymous Guest

    There are lots of neuro positions open. Why not move over here rather than leave?
     
  16. anonymous

    anonymous Guest

    Spot On! Look at the dismal track record of King Arthur! Fired, Fired, Fired!!!
     
  17. anonymous

    anonymous Guest

     
  18. anonymous

    anonymous Guest

    Stock price of $4.84 and dropping. National emergency declared on Opioids so Nucynta without abuse deterrence is hosed and the rest of the products are copy cat overpriced generics.
     
  19. anonymous

    anonymous Guest

    BUY BUY BUY !
     
  20. anonymous

    anonymous Guest

    Hah. Quit snorting that Nucynta. Revenue is down year over year, market valuation not even enough to cover the existing debt. The company is worthless on paper and all the potential buyers have moved on. Say hello to $3/share soon.